TMJ Pain
Conditions
Brief summary
These studies aim to validate the effects of photobiomodulation using clusters of 850nm LEDs (infrared) and 630nm LEDs (red); in pain and cervical and mandibular mobility in patients with TMD. It is a randomized, controlled, and blind clinical trial, which will consist of n= 36, of both genders, with ages ranging from 18 to 45 years, divided into 2 groups: Group 1 Red and infrared LED cluster, Group 2 placebo. The areas where they will receive photobiomodulation will be the TMJ area, masseter muscles, temporal muscles, scalenes, and trapezius. 6 non-consecutive sessions will be performed over 2 weeks. Diagnostic Criteria for Temporomandibular Disorders - DC/TMD will be used to determine TMD and validate participants. To validate the mandibular range of motion (ADM) a pachymeter will be used and for the cervical ADM a goniometer (fleximeter). The pain will be validated using the visual analog scale-VAS. All participants will be evaluated after the first therapeutic intervention, and again at the end, following the same validation procedures used initially.
Detailed description
The term temporomandibular disorders (TMD), according to the American American Dental Association (ADA), refers to a group of disorders characterized by pain in the temporomandibular joint (TMD) in the periauricular area or in the masticatory muscles, in addition to TMD sounds during jaw function and deviation or restriction of jaw movements. Its multifactorial etiology is related to a heterogeneous group of functional, structural, and psychological factors, making it difficult to identify the association between a single etiological factor and the signs and symptoms of TMD. As a treatment option, it hasphotobiomodulation, using different light sources, alone or in combination. These studies aim to validate the effects of photobiomodulation using clusters of 850nm LEDs (infrared) and 630nm LEDs (red); in pain and cervical and mandibular mobility in patients with TMD. It is a randomized, controlled, and blind clinical trial, which will consist of n= 36, of both genders, with ages ranging from 18 to 45 years, divided into 2 groups: Group 1 Red and infrared LED cluster, Group 2 placebo. The areas where they will receive photobiomodulation will be the TMJ area, masseter muscles, temporal muscles, scalenes, and trapezius. 6 non-consecutive sessions will be performed over 2 weeks. Diagnostic Criteria for Temporomandibular Disorders - DC/TMD will be used to determine TMD and validate participants. To validate the mandibular range of motion (ADM) a pachymeter will be used and for the cervical ADM a goniometer (fleximeter). The pain will be validated using the visual analog scale-VAS. All participants will be evaluated after the first therapeutic intervention, and again at the end, following the same validation procedures used initially.
Interventions
DEVICEPhotobiomodulation using LED
Photobiomodulation Using a Cluster of LEDs in the Red and Infrared Wavelengths in the Cervical Spine Region and Over the Masticatory Muscles
DEVICEPlacebo
Photobiomodulation Placebo
Sponsors
University of Nove de Julho
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* present TMD according Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I * have all permanent teeth
Exclusion criteria
* be undergoing orthodontic treatment * be undergoing other treatment for TMD * present dental caries or gingival disease. * Initiate or use any type of medication during the phases of the study * comorbidity
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Baseline | Before an intervention | Evaluation of Pain using visual analogic scale in centimeters (0-10cm) |
| Final Pain | 2 weeks after treatment | Evaluation of Pain using visual analogic scale in centimeters (0-10cm) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cervical spine mobility baseline | Before an intervention | Evaluation of cervical spine mobility using goniometer in degrees |
| Final Cervical spine mobility | 2 weeks after intervention | Evaluation of cervical spine mobility using goniometer in degrees |
| Mandibular mobility baseline | Before an intervention | Evaluation of mandibular mobility using caliper in millimeters |
| Final Mandibular mobility | 2 weeks after intervention | Evaluation of mandibular mobility using caliper in millimeters |
Countries
Brazil
Outcome results
None listed